New Evidence Associating Thimerosal-Containing Vaccines and other Childhood Vaccines with Autism Spectrum Disorder
This presentation will critically review the latest scientific evidence associating Thimerosal (mercury)-containing vaccines and other childhood vaccines with an increased risk of an autism spectrum disorder (ASD) diagnosis. Information will be presented regarding epidemiological assessments of the public Vaccine Adverse Event Reporting System (VAERS) database and the restricted access Vaccine Safety Datalink (VSD) database. Attendees will gain a clear perspective regarding the ASD-vaccine link.
Mark R. Geier, MD, PhD, FACE
Dr. Geier is a MD with a PhD in genetics, and is a Fellow of the American College of Epidemiology. Dr. Geier was a researcher at the National Institutes of Health for 10 years, and was previously a professor at the Johns Hopkins School of Medicine and at the Uniformed School of the Health Sciences. Dr. Geier has published more than 150 peer-reviewed scientific/medical articles, book chapters, and other publications.
David A. Geier, BA
Mr. Geier has a BA in Biology with a minor in History. Mr. Geier has been involved for more than 10 years in extensive research examining environmental factors linked to autism spectrum disorder (ASD) and the underlying biochemistry of ASD. Mr. Geier has published more than 100 peer-reviewed scientific/medical articles, book chapters, and other publications.
